Download PDF
1 / Pages

Other users also viewed these articles

Short-term response of p300 evoked potential in patients with minimal hepatic encephalopathy treated with l-ornithine, l-aspartate CI Hinojosa-Segura; D Montemira-Orozco; A Burak-Leipuner; J Zavala-Ramírez; IG Cruz-Reyes; M Escobedo-Silva; F Higuera-de la Tijera; JL Pérez-Hernández; D Santana-Vargas;
Ann Hepatol. 2022;27 Supl 3:
Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study AB Moreno-Cobos; F Higuera-de la Tijera; CI Hinojosa-Segura; D Montemira-Orozco; J Reyes-Méndez; IG Cruz-Reyes; J Zavala-Ramírez; D Santana-Vargas; A Servín-Caamaño; JM Abdo-Francis; JL Pérez- Hernandez;
Ann Hepatol. 2022;27 Supl 3:
Prevalence of high-risk non-alcoholic steatohepatitis according to the fast® index in a group of diabetic patients A Burak-Leipuner; F Higuera-de la Tijera; A Servín-Caamaño; J Romero-Bermúdez; L Ceceña-Martínez; F García-Gorrosquieta; N Uribe-Rivera; P Alagón-Fernández del Campo; F Vargas-Duran; C Hinojosa-Segura; D Montemira-Orozco; JL Pérez-Hernández;
Ann Hepatol. 2022;27 Supl 3: